P-0264

阿奇霉素直服颗粒（华益泰康药业）

Report date: 2026/03/04 20:01:44

Base Information

Drug NameP-0264
Drug Alias Name阿奇霉素直服颗粒（华益泰康药业）P-0264P0264
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesVisum Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesVisum Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A